Analysts Set Cresco Labs Inc. (OTCMKTS:CRLBF) Target Price at $2.50

Cresco Labs Inc. (OTCMKTS:CRLBF) has been given a consensus rating of “Moderate Buy” by the seven ratings firms that are presently covering the firm, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and two have given a strong buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $2.50.

CRLBF has been the subject of several recent analyst reports. Roth Capital raised shares of Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Needham & Company LLC reaffirmed a “hold” rating on shares of Cresco Labs in a research report on Monday, August 12th. Cormark lowered Cresco Labs from a “moderate buy” rating to a “hold” rating in a research report on Monday, November 11th. Finally, Ventum Cap Mkts raised Cresco Labs to a “strong-buy” rating in a research note on Friday, August 9th.

Cresco Labs Stock Down 5.0 %

Shares of OTCMKTS:CRLBF opened at $1.09 on Monday. The stock has a market capitalization of $533.29 million, a P/E ratio of -5.46 and a beta of 1.88. The stock’s 50-day moving average price is $1.52 and its 200-day moving average price is $1.66. The company has a current ratio of 1.97, a quick ratio of 1.39 and a debt-to-equity ratio of 1.80. Cresco Labs has a 12-month low of $1.02 and a 12-month high of $2.65.

About Cresco Labs

Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.